The prognosis and treatment of acquired hemophilia: A systematic review and meta-analysis

Blood Coagulation and Fibrinolysis

Volumn 20, Issue 7, 2009, Pages 517-523

  Bitting, Rhonda L ^a   Bent, Stephen ^a   Li, Yongmei ^b   Kohlwes, Jeffrey ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Acquired coagulation disorders; Hemophilia and other bleeding disorders; Immunotherapy; Other coagulation inhibitors

Indexed keywords

AZATHIOPRINE; CYCLOPHOSPHAMIDE; IMMUNOGLOBULIN; STEROID; VINCRISTINE; AUTOANTIBODY; BLOOD CLOTTING FACTOR 8;

ARTICLE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; DRUG EFFICACY; HEMOPHILIA A; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; META ANALYSIS; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; REMISSION; STEROID THERAPY; SURVIVAL RATE; SYSTEMATIC REVIEW; TREATMENT OUTCOME; AGED; FEMALE; IMMUNOLOGY; MALE; MIDDLE AGED; RISK FACTOR;

AGED; AUTOANTIBODIES; FACTOR VIII; FEMALE; HEMOPHILIA A; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; REMISSION INDUCTION; RISK FACTORS; SURVIVAL RATE;

EID: 70349829651     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/MBC.0b013e32832ca388     Document Type: Article

References (42)

1. Green D, Lechner K. A survey of 215 nonhemophilic patients with inhibitors to Factor VIII. Thromb Haemost 1981; 45:200-203.
2. Kasper CK, Aledort L, Aronson D, Counts R, Edson JR, van Eys J, et al. Proceedings: a more uniform measurement of factor VIII inhibitors. Thromb Diath Haemorrh 1975; 34:612.
3. Morrison AE, Ludlam CA, Kessler C. Use of porcine factor VIII in the treatment of patients with acquired hemophilia. Blood 1993; 81:1513-1520.
4. Tjonnfjord GE, Brinch L, Gedde-Dahl T, Brosstad FR. Activated prothrombin complex concentrate (FEIBA) treatment during surgery in patients with inhibitors to FVIII/IX. Haemophilia 2004; 10:174-178.
5. Sallah S. Treatment of acquired haemophilia with factor eight inhibitor bypassing activity. Haemophilia 2004; 10:169-173.
6. Hay CR, Negrier C, Ludlam CA. The treatment of bleeding in acquired haemophilia with recombinant factor VIIa: a multicentre study. Thromb Haemost 1997; 78:1463-1467.
7. Lottenberg R, Kentro TB, Kitchens CS. Acquired hemophilia. A natural history study of 16 patients with factor VIII inhibitors receiving little or no therapy. Arch Intern Med 1987; 147:1077-1081.
8. Delgado J, Jimenez-Yuste V, Hernandez-Navarro F, Villar A. Acquired haemophilia: review and meta-analysis focused on therapy and prognostic factors. Br J Haematol 2003; 121:21-35.
9. Watling M. The European acquired haemophilia registry. Blood Coagul Fibrinolysis 2004; 15 (Suppl 1):S29.
10. - 01 ACQUIRED HEMOPHILIA. Haemophilia 2006; 12:1-4.
11. Andersen NS, Friis-Hansen LJ, Scheibel E. [Acquired coagulation factor VIII deficiency. A 4-year survey of patients at the East Danish Hemophilia Center]. Ugeskr Laeger 1996; 158:2542-2545.
12. Bayer RL, Lichtman SM, Allen SL, Budman DR, Buchbinder A, Fetten J, et al. Acquired factor VIII inhibitors: successful treatment with an oral outpatient regimen. Am J Hematol 1999; 60:70-71.
13. Bossi P, Cabane J, Ninet J, Dhote R, Hanslik T, Chosidow O, et al. Acquired hemophilia due to factor VIII inhibitors in 34 patients. Am J Med 1998; 105:400-408. (Pubitemid 28536225)
14. Burnet SP, Duncan EM, Lloyd JV, Han P. Acquired haemophilia in South Australia: a case series. Intern Med J 2001; 31:556-559.
15. Collins P, Macartney N, Davies R, Lees S, Giddings J, Majer R. A population based, unselected, consecutive cohort of patients with acquired haemophilia A. Br J Haematol 2004; 124:86-90.
16. Delgado J, Villar A, Jimenez-Yuste V, Gago J, Quintana M, Hernandez- Navarro F. Acquired hemophilia: a single-center survey with emphasis on immunotherapy and treatment-related side-effects. Eur J Haematol 2002; 69:158-164.
17. Di Bona E, Schiavoni M, Castaman G, Ciavarella N, Rodeghiero F. Acquired haemophilia: experience of two Italian centres with 17 new cases. Haemophilia 1997; 3:183-188.
18. Dykes AC, Walker ID, Lowe GD, Tait RC. Combined prednisolone and intravenous immunoglobulin treatment for acquired factor VIII inhibitors: a 2-year review. Haemophilia 2001; 7:160-163.
19. Godreuil S, Navarro R, Quittet P, Landreau L, Schved JF, Biron-Andreani C. Acquired haemophilia in the elderly is a severe disease: report of five new cases. Haemophilia 2001; 7:428-432.
20. Grunewald M, Beneke H, Guthner C, Germowitz A, Brommer A, Griesshammer M. Acquired haemophilia: experiences with a standardized approach. Haemophilia 2001; 7:164-169.
21. Holme PA, Brosstad F, Tjonnfjord GE. Acquired haemophilia: management of bleeds and immune therapy to eradicate autoantibodies. Haemophilia 2005; 11:510-515.
22. Huang YW, Saidi P, Philipp C. Acquired factor VIII inhibitors in nonhaemophilic patients: clinical experience of 15 cases. Haemophilia 2004; 10:713-721.
23. Jansen M, Schmaldienst S, Banyai S, Quehenberger P, Pabinger I, Derfler K, et al. Treatment of coagulation inhibitors with extracorporeal immunoadsorption (Ig-Therasorb). Br J Haematol 2001; 112:91-97.
24. Ji L, Yang R, Yang D, Chen Z, Xing S, Tian M, et al. Prednisone and low-dose activated prothrombin complex concentrates for FVIII inhibitor in nonhaemophilic patients. Haemophilia 1998; 4:721-724.
25. Lian EC, Larcada AF, Chiu AY. Combination immunosuppressive therapy after factor VIII infusion for acquired factor VIII inhibitor. Ann Intern Med 1989; 110:774-778.
26. Lian EC, Villar MJ, Noy LI, Ruiz-Dayao Z. Acquired factor VIII inhibitor treated with cyclophosphamide, vincristine, and prednisone. Am J Hematol 2002; 69:294-295.
27. Liozon E, Delaire L, Turlure P, Jaccard A, Loustaud-Ratti V, Remenieras L, et al. [Acquired hemophilia caused by autoantibodies against factor VIII coagulation activity. Clinical, biological study and therapeutic indications. Experience based on a study of 9 cases]. Ann Med Interne 1997; 148:477-490.
28. Nemes L, Pitlik E. New protocol for immune tolerance induction in acquired hemophilia. Haematologica 2000; 85:64-68.
29. Ng HJ, Tan DC, Lee LH. Treatment and outcome of acquired haemophilia A with a standard conventional regimen in a cohort without associated conditions. Haemophilia 2006; 12:423-428.
30. Onitilo AA, Skorupa A, Lal A, Ronish E, Mercier RJ, Islam R, et al. Rituximab in the treatment of acquired factor VIII inhibitors. Thromb Haemost 2006; 96:84-87.
31. Pardos-Gea J, Ordi-Ros J, Altisent C, Balada E, Perez-Lopez J, Vilardell M. Acquired haemophilia A: successful treatment with immunosuppression, methylprednisolone pulses and oral cyclosporin. Thromb Haemost 2006; 95:735-737.
32. Rubinger M, Houston DS, Schwetz N, Woloschuk DM, Israels SJ, Johnston JB. Continuous infusion of porcine factor VIII in the management of patients with factor VIII inhibitors. Am J Hematol 1997; 56:112-118.
33. Sallah S, Singh P, Hanrahan LR. Antibodies against factor VIII in patients with solid tumors: successful treatment of cancer may suppress inhibitor formation. Haemostasis 1998; 28:244-249.
34. Sallah S, Nguyen NP, Abdallah JM, Hanrahan LR. Acquired hemophilia in patients with hematologic malignancies. Arch Pathol Lab Med 2000; 124:730-734.
35. Saxena R, Mishra DK, Kashyap R, Choudhry VP, Mahapatra M, Bhargava M. Acquired haemophilia: a study of ten cases. Haemophilia 2000; 6:78-83.
36. Schwartz RS, Gabriel DA, Aledort LM, Green D, Kessler CM. A prospective study of treatment of acquired (autoimmune) factor VIII inhibitors with highdose intravenous gammaglobulin. Blood 1995; 86:797-804.
37. Shaffer LG, Phillips MD. Successful treatment of acquired hemophilia with oral immunosuppressive therapy. Ann Intern Med 1997; 127:206-209.
38. Sohngen D, Specker C, Bach D, Kuntz BM, Burk M, Aul C, et al. Acquired factor VIII inhibitors in nonhemophilic patients. Ann Hematol 1997; 74:89-93.
39. Stasi R, Brunetti M, Stipa E, Amadori S. Selective B-cell depletion with rituximab for the treatment of patients with acquired hemophilia. Blood 2004; 103:4424-4428.
40. Tien SL, Tan P, Ong YW, Loh TF. Individualised treatment of seven cases of acquired factor VIII inhibitors. Ann Acad Med Singap 1991; 20:745-749.
41. Zeitler H, Ulrich-Merzenich G, Hess L, Konsek E, Unkrig C, Walger P, et al. Treatment of acquired hemophilia by the Bonn-Malmo Protocol: documentation of an in vivo immunomodulating concept. Blood 2005; 105:2287-2293.
42. Collins PW, Hirsch S, Baglin TP, Dolan G, Hanley J, Makris M, et al. Acquired hemophilia A in the United Kingdom: a 2-year national surveillance study by the United Kingdom Haemophilia Centre Doctors' Organisation. Blood 2007; 109:1870-1877.